Internal Moderna Report Tags Elon Musk, Novak Djokovic, and Russell Brand as ‘High Risk’
Moderna (NASDAQ: MRNA), the Boston-based pharmaceutical company known for its mRNA Covid-19 vaccine, has reportedly enlisted the services of former
Read more
Moderna
New COVID Variant Sweeps China, Is North America Next?
Remarkably, the world could be facing another bout with COVID this year, and with negative COVID test requirements having been
Read more
Moderna and Merck & Co: mRNA Cancer Vaccine Shows “Highly Encouraging Results,” Shares Rise
On Tuesday, Moderna (NASDAQ: MRNA) announced that their personalized cancer-vaccine program was successful in a midstage study of skin-cancer patients.
Read more
Moderna Shares Soar As Company Announces $3 Billion Stock Buyback
Moderna Inc (NASDAQ: MRNA) shares on Wednesday soared as high as 17% after it announced that it would be buying
Read more
Moderna To Construct Manufacturing Facility In Australia Under New Strategic Partnership
Moderna Inc (NASDAQ: MRNA) is officially going to the land down under. The company late last night announced that it
Read more
Moderna Shares Jump After Announcing Q4 2021 Earnings, US$19 Billion Advanced Sales
Moderna Inc (Nasdaq: MRNA) announced this morning its Q4 and full-year 2021 earnings. The vaccine manufacturer earned US$7.21 billion in revenue,
Read more
Moderna Expands Manufacturing Abilities In Spain, Steps Into New Asian Markets
Moderna Inc (NASDAQ: MRNA) is looking to scale up the production of its mRNA vaccines and therapeutics on a global
Read more
No, The CEO Of Moderna Didn’t Just Dump $400 Million In Shares
The trouble with social media, is that it’s a big game of telephone. One individual may go on a platform
Read more